Neoadjuvant Camrelizumab for Triple-Negative Breast Cancer

JAMA. 2024 Dec 13. doi: 10.1001/jama.2024.25927. Online ahead of print.

Author

Heikki Joensuu¹

Affiliation

¹ Department of Oncology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.

PMID: 39671279
DOI: 10.1001/jama.2024.25927

No abstract available